229 related articles for article (PubMed ID: 28969989)
21. Effect of sirolimus on liver cirrhosis and hepatic encephalopathy of common bile duct-ligated rats.
Wu KC; Huang HC; Chang T; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Lee FY; Chang CC; Lee SD
Eur J Pharmacol; 2018 Apr; 824():133-139. PubMed ID: 29444470
[TBL] [Abstract][Full Text] [Related]
22. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat.
Ling Y; Zhang J; Luo B; Song D; Liu L; Tang L; Stockard CR; Grizzle WE; Ku DD; Fallon MB
Hepatology; 2004 Jun; 39(6):1593-602. PubMed ID: 15185300
[TBL] [Abstract][Full Text] [Related]
23. Vildagliptin ameliorates intrapulmonary vasodilatation and angiogenesis in chronic common bile duct ligation-induced hepatopulmonary syndrome in rat.
Mangoura SA; Ahmed MA; Hamad N; Zaka AZ; Khalaf KA; Mahdy MA
Clin Res Hepatol Gastroenterol; 2024 Jun; 48(7):102408. PubMed ID: 38925324
[TBL] [Abstract][Full Text] [Related]
24. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M
J Hepatol; 2014 Jun; 60(6):1135-42. PubMed ID: 24530596
[TBL] [Abstract][Full Text] [Related]
25. Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
Li X; Chen Y; Wang L; Shang G; Zhang C; Zhao Z; Zhang H; Liu A
Braz J Med Biol Res; 2016 Jul; 49(7):. PubMed ID: 27383124
[TBL] [Abstract][Full Text] [Related]
26. Ascorbate lacks significant influence in rats with bile duct ligation-induced liver injury.
Ho HL; Huo TI; Chang T; Lee WS; Hsin IF; Lee FY; Huang HC; Hou MC; Lee SD
J Chin Med Assoc; 2017 Sep; 80(9):539-550. PubMed ID: 28684188
[TBL] [Abstract][Full Text] [Related]
27. A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.
Thenappan T; Goel A; Marsboom G; Fang YH; Toth PT; Zhang HJ; Kajimoto H; Hong Z; Paul J; Wietholt C; Pogoriler J; Piao L; Rehman J; Archer SL
Am J Respir Crit Care Med; 2011 Apr; 183(8):1080-91. PubMed ID: 21148721
[TBL] [Abstract][Full Text] [Related]
28. CXCR2 is involved in pulmonary intravascular macrophage accumulation and angiogenesis in a rat model of hepatopulmonary syndrome.
Li X; Chen Y; Chang Y; Li S; Zhao Z; Zhang H
Clin Sci (Lond); 2017 Jan; 131(2):159-168. PubMed ID: 27879294
[TBL] [Abstract][Full Text] [Related]
29. [Hepatopulmonary syndrome in liver cirrhosis].
Culafić Dj; Perisić M; Rebić P
Srp Arh Celok Lek; 2000; 128(7-8):271-5. PubMed ID: 11089435
[TBL] [Abstract][Full Text] [Related]
30. Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome.
Zhang M; Luo B; Chen SJ; Abrams GA; Fallon MB
Am J Physiol; 1999 Nov; 277(5):G944-52. PubMed ID: 10564099
[TBL] [Abstract][Full Text] [Related]
31. AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs.
Shen CC; Chen B; Gu JT; Ning JL; Zeng J; Yi B; Lu KZ
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):676-684. PubMed ID: 29233725
[TBL] [Abstract][Full Text] [Related]
32. Diosmin enhances the anti-angiogenic activity of sildenafil and pentoxifylline against hepatopulmonary syndrome via regulation of TNF-α/VEGF, IGF-1/PI3K/AKT, and FGF-1/ANG-2 signaling pathways.
Bakr AG; El-Bahrawy AH; Taha HH; Ali FEM
Eur J Pharmacol; 2020 Apr; 873():173008. PubMed ID: 32050083
[TBL] [Abstract][Full Text] [Related]
33. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome.
Fallon MB; Abrams GA; McGrath JW; Hou Z; Luo B
Am J Physiol; 1997 Apr; 272(4 Pt 1):G779-84. PubMed ID: 9142908
[TBL] [Abstract][Full Text] [Related]
34. Tea polyphenols and Levofloxacin alleviate the lung injury of hepatopulmonary syndrome in common bile duct ligation rats through Endotoxin -TNF signaling.
Zhu J; Qiu J; Chen K; Wang W; Zheng S
Biomed Pharmacother; 2021 May; 137():111263. PubMed ID: 33516071
[TBL] [Abstract][Full Text] [Related]
35. Arterial hypoxemia and intrapulmonary vasodilatation in rat models of portal hypertension.
Katsuta Y; Zhang XJ; Ohsuga M; Akimoto T; Komeichi H; Shimizu S; Kato Y; Miyamoto A; Satomura K; Takano T
J Gastroenterol; 2005 Aug; 40(8):811-9. PubMed ID: 16143886
[TBL] [Abstract][Full Text] [Related]
36. Nucleos(t)ide Analogs Do Not Independently Influence Hepatic Fibrosis and Portal Hypertension beyond Viral Suppression in CBDL-Induced Cirrhotic Rat.
Hsieh YH; Huang HC; Chang CC; Chuang CL; Lee FY; Hsu SJ; Huang YH; Hou MC; Lee SD
J Pharmacol Exp Ther; 2018 Nov; 367(2):260-266. PubMed ID: 30194095
[TBL] [Abstract][Full Text] [Related]
37. Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation.
Zhang XJ; Katsuta Y; Akimoto T; Ohsuga M; Aramaki T; Takano T
J Hepatol; 2003 Nov; 39(5):724-30. PubMed ID: 14568253
[TBL] [Abstract][Full Text] [Related]
38. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome.
Rabiller A; Nunes H; Lebrec D; Tazi KA; Wartski M; Dulmet E; Libert JM; Mougeot C; Moreau R; Mazmanian M; Humbert M; Hervé P
Am J Respir Crit Care Med; 2002 Aug; 166(4):514-7. PubMed ID: 12186830
[TBL] [Abstract][Full Text] [Related]
39. Pentoxifylline attenuation of experimental hepatopulmonary syndrome.
Zhang J; Ling Y; Tang L; Luo B; Chacko BK; Patel RP; Fallon MB
J Appl Physiol (1985); 2007 Mar; 102(3):949-55. PubMed ID: 17110505
[TBL] [Abstract][Full Text] [Related]
40. [Hepatopulmonary syndrome: physiopathology of impaired gas exchange].
Robert V; Chabot F; Vial B; Guiot P; Poussel JF; Polu JM
Rev Mal Respir; 1999 Nov; 16(5):769-79. PubMed ID: 10612146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
